Axys Pharmaceuticals' P2P Acquisition

Axys Pharmaceuticals raised a round of funding on June 13, 2001. Investors include Celera Genomics.

Axys Pharmaceuticals, formerly Arris Pharmaceuticals, develops a protease-inhibitor based products for cancer and inflammatory diseases.…

Articles about Axys Pharmaceuticals' P2P Acquisition: